Publications by authors named "Daniel Garcia-Ruiz de Morales"
Implementation of a program to improve influenza vaccination rates among medical students: a comparative study involving two university affiliated hospitals.
Miguel Saro-Buendía Ángel Marrero-Sánchez Daniel García-Ruiz de Morales Guillermo Chiara-Graciani Jaime Coderch-Carretero
Hum Vaccin Immunother
October 2021
: Influenza vaccination rates among medical students (MSs) are below the standards recommended in hospitals where influenza vaccination is not mandatory. We carried out a comparative study in two Spanish university hospitals to reassert this fact and evaluated the impact on vaccination rates of a specific program aimed at promoting influenza vaccination among MSs.: A descriptive cross-sectional study was performed describing influenza vaccination rates and motivations for vaccination during the 2017/18 campaign among MSs in two hospitals affiliated to the same university.
View Article and Find Full Text PDFCombination therapy with tocilizumab and corticosteroids for aged patients with severe COVID-19 pneumonia: A single-center retrospective study.
Francisco López-Medrano María Asunción Pérez-Jacoiste Asín Mario Fernández-Ruiz Octavio Carretero Antonio Lalueza Daniel García-Ruiz de Morales
Int J Infect Dis
April 2021
Article Synopsis
- A study examined the effects of combining systemic corticosteroids and tocilizumab in elderly patients (65+) with severe COVID-19 to see if it improves outcomes.
- Results indicated that patients receiving both treatments (CS-TCZ group) had significantly lower all-cause mortality rates by day 14 and 28 compared to those receiving only corticosteroids (CS group).
- Additionally, clinical improvement was more pronounced in the CS-TCZ group, suggesting that this combination therapy could be beneficial for older adults suffering from severe COVID-19.